What’s Hurting Colgate-Palmolive Stock?
Colgate-Palmolive (CL), which has disappointed so far this year with its soft sales and tepid margins, further disheartened investors by reducing its sales and earnings outlook for 2018. Management now expects its top line to see low-single-digit growth, down from its earlier guidance of mid-single digit growth. Colgate-Palmolive’s top line is likely to benefit from the company’s recent acquisition in North America.